作者: Susan Moore
DOI: 10.1097/01.NCC.0000265009.33053.2D
关键词:
摘要: Oral chemotherapy is assuming an increasingly important role in cancer therapy. Pharmaceutical firms continue to invest heavily oral drug development with approximately 25% of more than 400 antineoplastic drugs currently the pipeline planned as agents. New treatments, patient preference, and economic realities care delivery present physicians, nurses, pharmacists, center administrators a challenge restructure reorganize provide cost-effective high-quality patients. Oncology nurses are uniquely positioned step into new roles emphasizing family education support. A discussion Health Belief Model provides increased understanding motivation helps healthcare providers increase compliance among patients using therapies. This article overview current status therapy United States takes consideration historical perspective; illustrates pharmacology, indications, administration, side effect profile through exemplar agent; discusses potential advantages challenges integration therapies; alternative methods improve outcome.